Treatment of Hyperpigmentation skin on Macular Amyloidosis patient with using two different types of lasers
Phase 3
- Conditions
- L99.0Macular amyloid.Amyloidosis of skin
- Registration Number
- IRCT20080901001159N23
- Lead Sponsor
- Skin and Stem cell Research Center of Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Age more than 16 and less than 60
Skin phenotype between 3-5
lack of acute infection in part of body which is under laser treatment
Lack of inheritance and hormonal or malignant skin diseases
Exclusion Criteria
Using any drug related to decreasing pigment during last 2 weeks
Laser therapy in order to treat macular during last 1 month
No Solarium during last month
No pregnancy and breastfeeding.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Melanin Index. Timepoint: Before and after laser therapy. Method of measurement: Multi Probe adaptor.
- Secondary Outcome Measures
Name Time Method